Does Surgery for Breast Cancer Induce Angiogenesis and Thus Promote Metastasis? - Abstract - Oncology 2011, Vol. 81, No. 3-4 - Karger Publishers. To view the fulltext, please log in To view the pdf, please log in Buy FullText & PDF Unlimited re-access via MyKarger Unrestricted printing, no saving restrictions for personal use read more Select Buy a Karger Article Bundle (KAB) and profit from a discount! If you would like to redeem your KAB credit, please log in. Save over 20% compared to the individual article price. Learn more Rent/Cloud Rent for 48h to view Buy Cloud Access for unlimited viewing via different devices Synchronizing in the ReadCube Cloud Printing and saving restrictions apply Rental: USD 9.50 Cloud: USD 24.00 Select Subscribe Access to all articles of the subscribed year(s) guaranteed for 5 years Unlimited re-access via Subscriber Login or MyKarger Unrestricted printing, no saving restrictions for personal use read more Subcription rates Select * The final prices may differ from the prices shown due to specifics of VAT rules.
Article / Publication Details First-Page Preview ISSN: 0030-2414 (Print) eISSN: 1423-0232 (Online) T: : he tyrosine kinase c-Abl regulates p73 in apoptotic response to cisplatin-induced DNA damage : Abstract : Nature. Nature 399, 806-809 (24 June 1999) | doi:10.1038/21690; Received 21 April 1999; Accepted 6 May 1999 JianGen Gong1,5, Antonio Costanzo5,2, Hong-Qiong Yang1, Gerry Melino3, William G. Kaelin, Jnr4, Massimo Levrero2 & Jean Y. J. Wang1 Department of Biology and the Cancer Center, University of California, San Diego, La Jolla, California 92093-0322, USA Laboratory of Gene Expression, Fondazione A Cesalpino, University of Rome La Sapienza, Viale del Policlinico 155, 00161 Rome, Italy Biochemistry Laboratory, Istituto Dermopatico dell'Immacolata-IRCCS, Department of Experimental Medicine, University of Rome Tor Vergata 00133, Rome, Italy Howard Hughes Medical Institute, and Dana Farber Cancer Institute, Boston, Massachusetts 02115, USA These authors contributed equally to this work Top of page Cancer chemotherapeutic agents such as cisplatin exert their cytotoxic effect by inducing DNA damage and activating programmed cell death (apoptosis).
EpigeneticsCourseranotes. Non-coding RNAs in Colorectal Cancer. Chromatin Remodeling and the Control of Gene Expression. Carl Wu‡ + Author Affiliations Biochemical and genetic findings accumulated over the past decade have established that the condensation of eukaryotic DNA in chromatin functions not only to constrain the genome within the boundaries of the cell nucleus but also to suppress gene activity in a general manner. This genetic repression extends from the level of the nucleosome, the primary unit of chromatin organization, where coiling of DNA on the surface of the nucleosome core particle impedes access to the transcriptional apparatus, to the higher order folding of nucleosome arrays and the organization of silent regions of chromatin (for reviews see Refs. 1-6 and 105).
Chromatin structure is inextricably linked to transcriptional regulation, and recent studies show how chromatin is perturbed so as to facilitate transcription (for reviews see Refs. 7-12). Histone Acetylation Tetrahymena Histone Acetyltransferase A and Yeast Gcn5 P/CAF, p300/CBP, SAS, MOZ, and MOF Histone Deacetylases Perspectives. 20130467. Kiyoshi Nagai - MRC Laboratory of Molecular Biology. The removal of introns from nuclear pre-mRNA and splicing together of exons into a continuous translatable coding sequence is catalyzed by a large and dynamic RNA-protein machine known as the spliceosome. Five small nuclear ribonucleoprotein particles (U1, U2, U4/U6 and U5 snRNPs) and numerous non-snRNP factors assemble at each intron in the pre-mRNA to form a spliceosome.
Subsequently the spliceosome undergoes extensive compositional and structural changes to become catalytically active. How does the spliceosome assemble and carry out its function? How did a molecular machine as immense and complex as the spliceosome evolve in the Eukaryotic lineage? U1 snRNP binds to the 5’ splice site of pre-mRNA and initiates the assembly of the spliceosome. We determined the structure of yeast U4/U6.U5 tri-snRNP by cryoEM single-particle reconstruction first at 5.9 Å resolution (Nguyen et al., 2015) and then at 3.7 Å overall resolution (Nguyen et al., 2016).
Selected Papers Galej, W. Group Members. British Society for Gene and Cell Therapy. Spindle transfer for Mitochondrial Replacement Therapy | British Society for Gene and Cell Therapy. This article from the Mitalipov group (Kang et al. 2016) came out at a particularly interesting time, since it followed closely on the report from a US-based team in Mexico on the successful birth of a baby to a mother with the mitochondrial mutation causing Leigh syndrome, which had been corrected by transfer of maternal nuclear DNA to a donor oocyte (Hamzelou 2016).
It was also published on the same day as the decision by the HFEA that clinics are now free to apply for permission to carry out mitochondrial replacement, with the first patients expected to be seen as early as Spring 2017 (Forster 2016). The paper from Kang et al., (2016) details studies performed with oocytes from four families with Leigh syndrome and one with MELAS, both associated with mutations in mitochondrial DNA (mtDNA). Characterisation of the mtDNA burden in tissues from the patients and their children highlighted the problem with genetic testing for this condition. References Forster, K. (2016). Hyslop, L. Dr Luca Magnani. Summary Cancer cells exhibit altered transcriptional profiles when compared to their tissue of origin. Genetic alterations participate in promoting defective transcription, however they don't explain the full spectrum of aberrations found in malignant tissues. Gene expression is also controlled via modifications of the chromatin landscape including DNA methylation, histone modifications and chromatin remodelling.